指南与共识血栓与止血

ISTH SSC关于血友病年出血率定义、记录与报告标准化的建议

Recommendations for harmonizing definition, recording, and reporting of the annual bleeding rate in hemophilia: communication from the ISTH SSC Subcommittee on Factor VIII, Factor IX and Rare Coagulation Disorders.
指南 / 共识 · J Thromb Haemost · 2026-09-09

国际血栓与止血学会科学标准化委员会(ISTH SSC)因子VIII、因子IX及罕见凝血障碍小组针对血友病年出血率(ABR)定义与报告不统一的问题,修订了关节出血定义,并提出出血事件记录、疗效期及出血率计算的标准化建议,以支持临床试验与临床实践中新疗法的比较和共享决策。

要点

  • 推荐在临床试验和实践中统一应用修订后的关节出血定义。
  • 建议标准化记录出血事件,包括部位、自发性与创伤性区分。
  • 推荐统一疗效期和出血率计算方法,以便比较不同治疗。

核心结论

  • 建议未来临床试验和实践中应用修订的关节出血定义及出血事件报告标准,以支持新疗法比较和共享决策。

研究设计与样本

  • ISTH SSC因子VIII、因子IX及罕见凝血障碍小组 convened 新工作组,回顾文献并邀请利益相关方,制定出血事件识别、记录和报告建议。

主要发现

  • 2014年SSC工作组曾提供关节和肌肉出血事件定义,但未被临床试验或实践一致应用。
  • 文献在报告汇总出血事件时差异很大,包括部位、自发性与创伤性出血区分、数据集中趋势和观察期等方面。
  • 新工作组提供了修订的关节出血定义,以及统一报告出血事件的建议,包括疗效期和出血率计算。

关键数值与推荐

  • 修订了关节出血定义,并建议统一报告出血事件,包括疗效期和出血率计算。

临床怎么用

  • 在临床实践和未来临床试验中应用修订的关节出血定义及标准化报告方法,以支持疗法比较和共享决策。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Bleeding manifestations not only correlate with the severity of hemophilia but are also used to assess the efficacy of treatment. Accurate identification of bleeding events and their frequency, along with harmonized reporting, is crucial for assessing the efficacy of therapeutic interventions. Bleeding into large joints, the most common manifestation of severe hemophilia, can be challenging to recognize, especially when very mild or associated with preexisting arthropathy. A previous International Society on Thrombosis and Haemostasis Scientific and Standardization Committee (SSC) working group provided definitions for determining joint and muscle bleed events in 2014, but these have not been consistently applied in clinical trials or practice. Additionally, the literature varies widely in reporting aggregate bleed events, including by site, differentiation between spontaneous and traumatic bleeds, the central tendencies of the data, and the observation period over which the data are collected. These aspects were not covered in the previous SSC recommendations. A new SSC working group was therefore convened to review the available literature and engage stakeholders to prepare recommendations for recognizing bleed events, particularly in the joints, as well as their recording and reporting, including terminology and methods for communicating aggregate data. Here, we provide a revised definition of joint bleeding, along with recommendations to harmonize reporting of bleeding events, including the efficacy period and calculation of bleeding rates. It is recommended that these definitions be applied in future clinical trials and practice to support comparisons of novel treatments and shared decision-making.

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. Srivastava A, Croteau SE, Castaman G, et al. Recommendations for harmonizing definition, recording, and reporting of the annual bleeding rate in hemophilia: communication from the ISTH SSC Subcommittee on Factor VIII, Factor IX and Rare Coagulation Disorders. J Thromb Haemost. 2026. PMID: 42716226. doi:10.1016/j.jtha.2026.08.034

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。